Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.

Baber, U; Dangas, G; Cohen, DJ; Gibson, CM; Mehta, SR; Angiolillo, DJ; Pocock, SJ; Krucoff, MW; Kastrati, A; Ohman, EM; +7 more... Steg, PG; Badimon, J; Zafar, MU; Chandrasekhar, J; Sartori, S; Aquino, M; Mehran, R; (2016) Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. American heart journal, 182. pp. 125-134. ISSN 0002-8703 DOI: https://doi.org/10.1016/j.ahj.2016.09.006

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.ahj.2016.09.006

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar